CLIA Chlamydia trachomatis IgA
Chemiluminescence kit for the detection of IgA antibodies to Chlamydia trachomatis in human serum or plasma
New
Chemiluminescence kit for the detection of IgA antibodies to Chlamydia trachomatis in human serum or plasma
| Catalog Number: | CL-ChtA100 |
|---|---|
| Size: | 100 tests |
| Regulatory status: | CE IVD |
| Clinical topic: | Infectious Diseases |
| Diagnostic panel: | Sexually Transmitted Infections (STIs) |
Chlamydia is caused by the gram-negative, obligate intracellular bacterium Chlamydia trachomatis. Globally, it is the most prevalent sexually transmitted bacterial infection. The organism causes genitourinary infections in women and men, the disease often remains asymptomatic. Sexually active young people between 15 and 30 years of age are most at risk of chlamydia. The most common complications are pelvic inflammatory disease (PID) and salpingitis, conditions that can lead to infertility in both men and women and extra-uterine pregnancies. Cervical chlamydia infection is currently considered to be one of the risk factors for uterine cervix carcinoma.
Once detected, the infection is easily treated by a short course of antibiotic therapy.
| Assay time | 30 min |
| Assay stability | 30 days on board stability / In use stability until the expiration date at storage temperature 2-8 °C |
| Sample matrix | Serum, Plasma |
| Sample volume | 10 µL |
| Measuring range | 2-320 U/ml |
| Assay/kit content | Reagent Cartridge with specific reagents for the assay, magnetic particles, calibrators |
| Complementary products | Wash buffer, Anchor® Tips, Stackable cuvettes, Trigger solutions |
| Note | The kits are CE-IVD certified and intended for professional use. |